Bethany Sensenig is Chief Financial Officer of 9 METERS BIOPHARMA, INC.. Currently has a direct ownership of 41,077 shares of NMTR, which is worth approximately $821. The most recent transaction as insider was on Apr 21, 2023, when has been sold 9,100 shares (Common Stock) at a price of $1.21 per share, resulting in proceeds of $11,011. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 41.1K
0% 3M change
0% 12M change
Total Value Held $821

Bethany Sensenig Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 21 2023
SELL
Open market or private sale
$11,011 $1.21 p/Share
9,100 Reduced 18.14%
41,077 Common Stock
Mar 27 2023
BUY
Grant, award, or other acquisition
-
50,177 Added 50.0%
50,177 Common Stock

Also insider at

SUPN
SUPERNUS PHARMACEUTICALS, INC. Healthcare
BS

Bethany Sensenig

Chief Financial Officer
Raleigh, NC

Track Institutional and Insider Activities on NMTR

Follow 9 METERS BIOPHARMA, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NMTR shares.

Notify only if

Insider Trading

Get notified when an 9 Meters Biopharma, Inc. insider buys or sells NMTR shares.

Notify only if

News

Receive news related to 9 METERS BIOPHARMA, INC.

Track Activities on NMTR